Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
Guidance on rosiglitazone for...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
Guidance on rosiglitazone for type 2 diabetes mellitus.
Bibliográfalaš dieđut
Váldodahkki:
Matthews, DR
Materiálatiipa:
Journal article
Giella:
English
Almmustuhtton:
2001
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Govvádus
Čoahkkáigeassu:
Geahča maid
Guidance on rosiglitazone for type 2 diabetes mellitus [7] (multiple letters)
Dahkki: Matthews, DR, et al.
Almmustuhtton: (2001)
Rosiglitazone-associated fractures in type 2 diabetes
Dahkki: Kahn, SE, et al.
Almmustuhtton: (2008)
Budget impact of rosiglitazone in type 2 diabetes
Dahkki: Orietta Zaniolo, et al.
Almmustuhtton: (2007-03-01)
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
Dahkki: Y. Atamer, et al.
Almmustuhtton: (2013-01-01)
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
Dahkki: Y. Atamer, et al.
Almmustuhtton: (2013-06-01)